Found 4 resultsAuthor Title Type [ Year]
Filters: Author is Appelbaum, Frederick R [Clear All Filters]
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials. Biol Blood Marrow Transplant, 24(6), 1274-1280. presented at the 2018 06. doi:10.1016/j.bbmt.2018.01.002. (2018).
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant, 21(1), 4-7. presented at the 2015 Jan. doi:10.1016/j.bbmt.2014.09.017. (2015).
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and M. Biol Blood Marrow Transplant, 20(10), 1566-72. presented at the 2014 Oct. doi:10.1016/j.bbmt.2014.06.010. (2014).
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transpl. J Clin Oncol, 30(26), 3194-201. presented at the 2012 Sep 10. doi:10.1200/JCO.2012.41.7071. (2012).